Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents

BACKGROUND: The devastating impact of the SARS-CoV-2 pandemic prompted the development and emergency use authorization of two mRNA vaccines in early 2020. Vaccine trials excluded nursing home (NH) residents, limiting adverse event data that directly apply to this population. METHODS: To prospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardenheier, Barbara H., Gravenstein, Stefan, Blackman, Carolyn, Gutman, Roee, Sarkar, Indra Neil, Feifer, Richard A., White, Elizabeth M., McConeghy, Kevin, Nanda, Aman, Mor, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162901/
https://www.ncbi.nlm.nih.gov/pubmed/34092431
http://dx.doi.org/10.1016/j.vaccine.2021.05.088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162901/
https://www.ncbi.nlm.nih.gov/pubmed/34092431
http://dx.doi.org/10.1016/j.vaccine.2021.05.088

Ejemplares similares